Dear EU Commission – think carefully


There is a lot at stake as the EU Commission presents its proposals for the revision of the general pharmaceutical legislation, as well as the legislation concerning medicines for children and rare diseases. These proposals follow the EU Commission's previously announced pharmaceutical strategy for Europe.

Dear EU Commission – think carefully2023-11-03T14:56:54+01:00

Don’t forget the rare but collectively common diseases


There are significant human and societal gains to be made through rapid, accurate, and effective diagnosis and treatment of the 6-8% of the population living with a rare disease.

Don’t forget the rare but collectively common diseases2023-11-03T14:59:08+01:00
Go to Top